Abstract
Millions of people are afflicted with psoriasis, which is a chronic inflammatory skin disease throughout the world. Despite modern treatments for psoriasis remain unmet needs and challenges in achieving optimal results. This review article aims to present a multidimensional view of the research and therapy for psoriasis, which encompasses not only the cellular and molecular mechanisms but also the network pharmacology of traditional Chinese medicine, novel therapeutic targets and strategies as well as autophagy plays a role on psoriasis pathogenesis or treatment. At the same time discussion on bimekizumab, once was declared an initial proof of concept biological agent that acts by both inhibiting interleukin-17 A and F (two cytokines slightly different) in psoriasis.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
